Related Experiment Video
Updated: May 4, 2026
05:15
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
4.5K
Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable
Yap P Chuan1, Nani Wibowo, Natalie K Connors
1Australian Institute for Bioengineering and Nanotechnology, Centre for Biomolecular Engineering, University of Queensland, St. Lucia, QLD, 4072, Australia.
Biotechnology and Bioengineering
|December 17, 2013
Summary
Developing novel virus-like particle (VLP) and capsomere systems for group A streptococcus (GAS) vaccines shows promise for broad-coverage and low-cost immunization strategies against GAS infections.
Area of Science:
- Vaccinology
- Microbial Pathogenesis
- Immunology
Background:
- Severe group A streptococcus (GAS) infections pose a significant global health burden, particularly in low-income countries and Indigenous Australian communities.
- Existing GAS strains are diverse, necessitating the development of broad-coverage vaccines tailored to endemic strains.
- Current vaccine development faces challenges in achieving effective and affordable solutions for widespread GAS control.
Purpose of the Study:
- To evaluate modular virus-like particle (VLP) and capsomere systems for delivering cross-reactive GAS antigens.
- To assess the immunogenicity and efficacy of these delivery systems in a preclinical setting.
- To explore the potential for developing multivalent, broad-coverage GAS vaccines.
Main Methods:
- Utilized modular VLPs and capsomeres to present three N-terminal M-protein peptides (GAS1, GAS2, GAS3) from endemic Australian GAS strains.
- Administered peptides via unadjuvanted VLPs and adjuvanted capsomeres in vivo.
- Measured peptide-specific IgG antibody titers and assessed cross-reactivity between induced antibodies and different GAS peptides.
Main Results:
- Both VLP and capsomere systems induced high titers of peptide-specific IgG antibodies (>1 × 10^4).
- Capsomere delivery showed superior efficacy for the GAS3 peptide compared to VLP, indicating antigen-dependent system effectiveness.
- Significant cross-reactivity was observed between GAS2-induced IgG and GAS1, supporting broad-coverage vaccine design.
- A multivalent VLP formulation with three GAS peptides at low doses successfully induced specific IgG titers for each peptide.
Conclusions:
- Modular VLPs and capsomeres represent innovative and promising platforms for GAS vaccine development.
- These systems facilitate the design of broad-coverage vaccines by utilizing cross-reactive antigens.
- The potential for microbial synthesis and adoption by developing countries makes this approach highly valuable for global GAS control.
More Related Videos
Related Concept Videos
00:56Viral Structure
59.0K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
59.0K
01:29Viruses of Archaea
704
Archaeal viruses play a crucial role in the ecosystems of extremophilic archaea, particularly those belonging to the phyla Euryarchaeota and Crenarchaeota. By shaping host evolution and facilitating gene transfer, these viruses influence microbial communities and contribute to genetic diversity in extreme environments. The archaea they infect thrive in acidic hot springs and hydrothermal vents characterized by high temperatures and low pH. Archaeal viruses exhibit remarkable structural...
704
01:28Introduction to Virus
2.9K
Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
2.9K
01:29Subviral Agents
933
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
933
02:41Protein Complex Assembly
12.5K
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types. Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Many viruses self-assemble into a fully functional unit using the infected host cell to...
12.5K
01:30Lytic Cycle of Bacteriophages
60.2K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
60.2K